Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Annals of Hematology
Published in: Annals of Hematology 9/2016

01-09-2016 | Letter to the Editor

Rhodotorula mucilaginosa as a cause of recurrent pulmonary infection and liver infiltration in a patient with CLL

Authors: Julia Fischer, L. Hamacher, J. Fries, M. Hallek, O. A. Cornely, M. Kochanek, B. Boell

Published in: Annals of Hematology | Issue 9/2016

Login to get access

Excerpt

Dear Editor, …
Literature
1.
2.
Safdar A, Armstrong D (2001) Infectious morbidity in critically ill patients with cancer. Crit Care Clin 17(3):531–570 vii-viiiCrossRefPubMed
3.
Auberger J et al. (2012) Invasive fungal breakthrough infections, fungal colonization and emergence of resistant strains in high-risk patients receiving antifungal prophylaxis with posaconazole: real-life data from a single-centre institutional retrospective observational study. J Antimicrob Chemother 67(9):2268–2273CrossRefPubMed
4.
Garcia-Suarez J et al. (2011) Epidemiology and outcome of Rhodotorula infection in haematological patients. Mycoses 54(4):318–324CrossRefPubMed
5.
Tuon FF, Costa SF (2008) Rhodotorula infection. A systematic review of 128 cases from literature. Rev Iberoam Micol 25(3):135–140CrossRefPubMed
6.
Nunes JM et al. (2013) Molecular identification, antifungal susceptibility profile, and biofilm formation of clinical and environmental Rhodotorula species isolates. Antimicrob Agents Chemother 57(1):382–389CrossRefPubMedPubMedCentral
Metadata
Title
Rhodotorula mucilaginosa as a cause of recurrent pulmonary infection and liver infiltration in a patient with CLL
Authors
Julia Fischer
L. Hamacher
J. Fries
M. Hallek
O. A. Cornely
M. Kochanek
B. Boell
Publication date
01-09-2016
Publisher
Springer Berlin Heidelberg
Published in
Annals of Hematology / Issue 9/2016
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-016-2726-7

Other articles of this Issue 9/2016

Annals of Hematology 9/2016 Go to the issue

Original Article

Infectious diseases in allogeneic haematopoietic stem cell transplantation: prevention and prophylaxis strategy guidelines 2016

Letter to the Editor

A case of BK virus nephropathy without hemorrhagic cystitis after hematopoietic stem cell transplantation

Letter to the Editor

Congenital dyserythropoietic anemia associated to a GATA1 mutation aggravated by pyruvate kinase deficiency

Original Article

Prognostic factors of early outcome in pediatric hemophagocytic lymphohistiocytosis: an analysis of 116 cases

Letter to the Editor

Hereditary xerocytosis, a misleading anemia

Original Article

Health care setting and severity, symptom burden, and complications in patients with Philadelphia-negative myeloproliferative neoplasms (MPN): a comparison between university hospitals, community hospitals, and office-based physicians
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits